Literature DB >> 11090750

Evaluation of the roche AMPLICOR enterovirus PCR assay in the diagnosis of enteroviral central nervous system infections.

K C Carroll1, B Taggart, J Robison, C Byington, D Hillyard.   

Abstract

BACKGROUND: Enteroviruses cause a substantial number of cases of aseptic meningitis annually in the USA. While culture has been useful in the detection of patients with viral meningitis it is time-consuming and lacks sensitivity. Detection of viral nucleic acid in patient specimens has been demonstrated to improve enteroviral detection.
OBJECTIVES: A research use only commercial amplification assay, the Roche AMPLICOR EV test, was compared to culture for the diagnosis of enteroviral meningoencephalitis. STUDY
DESIGN: Four-hundred and sixty-five consecutive CSF samples sent prospectively for suspicion of enteroviral infection were evaluated by PCR and shell-vial culture. Clinical information and CSF analysis were used to resolve PCR positive, culture negative samples. Sensitivity and specificity were calculated using resolved data.
RESULTS: There were 138 samples which met the definition of a true positive. Of these culture detected 77 (sensitivity 55.8%) and PCR detected 136 (sensitivity 98.6%). PCR missed two culture positive samples. Upon repeat testing, these CSF samples were found to contain inhibitors.
CONCLUSIONS: The Roche AMPLICOR EV-PCR test was statistically more sensitive than culture (P<0.001) in the detection of enteroviruses in CSF in patients suspected of having enteroviral meningitis. This assay also has the advantage of a rapid turnaround time of 5-6 h compared to 3-5 days for culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090750     DOI: 10.1016/s1386-6532(00)00115-3

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

1.  Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid.

Authors:  Christine C Ginocchio; Frank Zhang; Amisha Malhotra; Ryhana Manji; Peter Sillekens; Helma Foolen; Marlieke Overdyk; Margot Peeters
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Evaluation of LightCycler as a platform for nucleic acid sequence-based amplification (NASBA) in real-time detection of enteroviruses.

Authors:  Anna-Maria Costa; David Lamb; Suzanne M Garland; Sepehr N Tabrizi
Journal:  Curr Microbiol       Date:  2007-10-02       Impact factor: 2.188

3.  Enhanced detection of enteroviruses in clinical samples by reverse transcription-PCR using complementary locked primer technology.

Authors:  JiYoung Hong; Byunghak Kang; Ahyoun Kim; Seoyoun Hwang; Sunwha Lee; Jonghyen Kim; Hyun-Young Lee; Sang-Hyeon Kang; Doo-Sung Cheon
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

4.  Costs and infant outcomes after implementation of a care process model for febrile infants.

Authors:  Carrie L Byington; Carolyn C Reynolds; Kent Korgenski; Xiaoming Sheng; Karen J Valentine; Richard E Nelson; Judy A Daly; Russell J Osguthorpe; Brent James; Lucy Savitz; Andrew T Pavia; Edward B Clark
Journal:  Pediatrics       Date:  2012-06-25       Impact factor: 7.124

Review 5.  Enterovirus and parechovirus infection in children: a brief overview.

Authors:  S C M de Crom; J W A Rossen; A M van Furth; C C Obihara
Journal:  Eur J Pediatr       Date:  2016-05-07       Impact factor: 3.183

Review 6.  Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Authors:  P Fillatre; Y Crabol; P Morand; L Piroth; J Honnorat; J P Stahl; M Lecuit
Journal:  Med Mal Infect       Date:  2017-03-15       Impact factor: 2.152

Review 7.  PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings.

Authors:  Samuel Yang; Richard E Rothman
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.